INVESTORS Annual Reports Financials Investor Presentations Shareholder Information Analysts Speak Events Corporate Policies
CAREERS Careers Overview Life at Lupin Campus Connect Learning & Development Current Openings P.L.E.D.G.E.
MEDIA Press Releases Downloadables
CONTACT US Contact Us Global Offices Partner With Us Lupin for Suppliers


The Australian pharmaceutical market was valued at USD 13 billion in 2017 with Generics accounting for over 30% of the sales volume. Our Australian subsidiary, Generic Health Pty Limited (Generic Health), had a strong year recording revenues of AUD 43 million and reported a growth of 28%, significantly outperforming the generic market growth. Generic Health is a supplier of generic prescriptions and OTC medicines, is the 5th largest company in sales and one of the fastest growing companies amongst its peers.